(Q63597593)

English

Imatinib for Multiple Sclerosis (MS) Relapses

clinical trial

Statements

Imatinib for Multiple Sclerosis (MS) Relapses - a Phase II, Randomised Study (English)
0 references
0 references
0 references
0 references
0 references
0 references
1 October 2018
0 references
31 December 2020
0 references
200
0 references
18 year
0 references
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit